SCHEMBL23959236

SCHEMBL23959236

c1ccc(-c2nc3ncc(-c4ccc(N5c6ccccc6S(c6ccccc6)(c6ccccc6)c6ccccc65)cc4)cn3c2-c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 10/20 0.51
▸ AKT2 P31751 10/20 0.51
▸ ROCK2 O75116 1/20 0.36
▸ PIM1 P11309 1/20 0.36
▸ GSK3B P49841 1/20 0.36
▸ MEN1 O00255 1/20 0.32
▸ USP2 O75604 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ MAP4K4 O95819 1/20 0.32
▸ PAK4 O96013 1/20 0.32
▸ CSF1R P07333 1/20 0.32
▸ RET P07949 1/20 0.32
▸ GRK5 P34947 1/20 0.32
▸ MAPK8 P45983 1/20 0.32
▸ CSNK1A1 P48729 1/20 0.32
▸ ACVR1 Q04771 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23959251 0.87 AKT1 (0.58) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959310 0.82 AKT1 (0.56) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959235 0.82 AKT1 (0.53) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959234 0.80 AKT1 (0.54) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL23959250 0.78 AKT1 (0.53) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL22484956 0.77 PDE6D (0.38) MEN1HPGDKMT2AL3MBTL1
SCHEMBL23959205 0.76 AKT1 (0.47) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL22522876 0.75 L3MBTL1 (0.37) MEN1USP2HPGDMAPK1KMT2A
SCHEMBL23959207 0.73 AKT1 (0.56) AKT1AKT2ROCK2PIM1GSK3B
SCHEMBL22871622 0.73 L3MBTL1 (0.35) MEN1HPGDKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-12-07 — — US disclosed
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2021-10-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192901-B2 Nitrogen-containing heterocyclic organic compound and organic electroluminescent device H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885ROCK2 2074/4885
US-20210332066-A1 NITROGEN-CONTAINING HETEROCYCLIC ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE H1-10, H1-0, OR10J3 AKT1 1176/4885AKT2 1711/4885ROCK2 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback